Desktop Roaming Solutions Improve Healthcare
Imprivata's OneSign Single Sign On is proving to be beneficial for Augusta Health Care
Recently, Health IT Outcomes reported how Imprivata's desktop roaming solutions are proving benefits to the healthcare industry. The article cited an Imprivata survey that found, "Fewer than 30 percent of healthcare organizations in the U.S. use cloud-based applications and services, but over the next 24 months, the use of cloud computing is expected to increase by 57 percent.” The survey further found three of four respondents use Server Based Computing and over half use Server Hosted Virtual Desktops."
Health IT Outcomes spoke with Bruce Hall, CIO of Augusta Health Care, at HIMSS14 and Hall explained how Imprivata is working for them. Hall explains a common contradiction that many people have is that the "need to make our systems very accessible at the same time as protecting the data they are collecting in their system.” Hall explained one way to address this contradiction is to "create seamless access to our computer systems."
Hall further details that by working with Imprivata’s solutions, physicians have the ability to access their system and "go from device to device and their desktop follows them." When asked about the results he has seen using Imprivata, Hall mentioned how it is saving them a tremendous amount of money, as well as saving physicians time as they no longer have to log in and out of systems numerous times per day. Hall concludes Imprivata’s solutions have saved “three FTE's of nursing time."
The American Hospital Association awarded the Imprivata OneSign Single Sign-On an exclusive endorsement, concluding, "In our evaluation, Imprivata has distinguished itself with the breadth of its solution and depth of technical integration with EMR vendors and virtual desktop infrastructure providers. Customer references indicate high satisfaction, and time savings for care providers is significant with Single Sign-On from Imprivata. These results have been validated by independent research from KLAS and Ponemon Institute."